Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | -1.21% | -5.06% | +82.09% |
May. 07 | Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 172M |
---|---|---|---|---|---|
Net income 2024 * | -43M | Net income 2025 * | -53M | EV / Sales 2024 * | - |
Net cash position 2024 * | 107M | Net cash position 2025 * | 188M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.71
x | P/E ratio 2025 * |
-5.3
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.71% |
Latest transcript on Trevi Therapeutics, Inc.
1 day | -1.21% | ||
1 week | -5.06% | ||
Current month | -5.06% | ||
1 month | -16.44% | ||
3 months | -14.08% | ||
6 months | +112.17% | ||
Current year | +82.09% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Thomas Sciascia
FOU | Founder | 70 | 10-12-31 |
Lisa Delfini
DFI | Director of Finance/CFO | 54 | 21-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne VanLent
BRD | Director/Board Member | 76 | 18-10-09 |
James Cassella
BRD | Director/Board Member | 69 | 20-02-12 |
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.44 | -1.21% | 91,699 |
24-06-06 | 2.47 | -7.49% | 124,319 |
24-06-05 | 2.67 | +2.30% | 305,026 |
24-06-04 | 2.61 | +2.35% | 230,859 |
24-06-03 | 2.55 | -0.78% | 177,900 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.09% | 172M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.84% | 22.78B | |
-10.63% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- TRVI Stock